209 related articles for article (PubMed ID: 9396787)
1. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors.
Chen WJ; Armour S; Way J; Chen G; Watson C; Irving P; Cobb J; Kadwell S; Beaumont K; Rimele T; Kenakin T
Mol Pharmacol; 1997 Dec; 52(6):1164-75. PubMed ID: 9396787
[TBL] [Abstract][Full Text] [Related]
2. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of novel amylin-binding sites with calcitonin receptors in human breast carcinoma MCF-7 cells.
Zimmermann U; Fluehmann B; Born W; Fischer JA; Muff R
J Endocrinol; 1997 Dec; 155(3):423-31. PubMed ID: 9487987
[TBL] [Abstract][Full Text] [Related]
4. Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: potential models for studying CGRP/amylin receptor subtypes.
Aiyar N; Baker E; Martin J; Patel A; Stadel JM; Willette RN; Barone FC
J Neurochem; 1995 Sep; 65(3):1131-8. PubMed ID: 7643091
[TBL] [Abstract][Full Text] [Related]
5. In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain.
Paxinos G; Chai SY; Christopoulos G; Huang XF; Toga AW; Wang HQ; Sexton PM
J Chem Neuroanat; 2004 Jul; 27(4):217-36. PubMed ID: 15261329
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney.
Chai SY; Christopoulos G; Cooper ME; Sexton PM
Am J Physiol; 1998 Jan; 274(1):F51-62. PubMed ID: 9458823
[TBL] [Abstract][Full Text] [Related]
7. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.
Muff R; Bühlmann N; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2924-7. PubMed ID: 10342886
[TBL] [Abstract][Full Text] [Related]
8. Amylin is an agonist of the renal porcine calcitonin receptor.
Sexton PM; Houssami S; Brady CL; Myers DE; Findlay DM
Endocrinology; 1994 May; 134(5):2103-7. PubMed ID: 8156909
[TBL] [Abstract][Full Text] [Related]
9. Characterization of amylin binding sites in a human hepatoblastoma cell line.
Sheriff S; Fischer JE; Balasubramaniam A
Peptides; 1992; 13(6):1193-9. PubMed ID: 1337379
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats.
Vine W; Beaumont K; Gedulin B; Pittner R; Moore CX; Rink TJ; Young AA
Eur J Pharmacol; 1996 Oct; 314(1-2):115-21. PubMed ID: 8957226
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
Armour SL; Foord S; Kenakin T; Chen WJ
J Pharmacol Toxicol Methods; 1999 Dec; 42(4):217-24. PubMed ID: 11033437
[TBL] [Abstract][Full Text] [Related]
12. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
13. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
14. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain.
Christopoulos G; Paxinos G; Huang XF; Beaumont K; Toga AW; Sexton PM
Can J Physiol Pharmacol; 1995 Jul; 73(7):1037-41. PubMed ID: 8846397
[TBL] [Abstract][Full Text] [Related]
15. High affinity amylin binding sites in rat brain.
Beaumont K; Kenney MA; Young AA; Rink TJ
Mol Pharmacol; 1993 Sep; 44(3):493-7. PubMed ID: 8396712
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.
Beaumont K; Moore CX; Pittner RA; Prickett KS; Gaeta LS; Rink TJ; Young AA
Can J Physiol Pharmacol; 1995 Jul; 73(7):1025-9. PubMed ID: 8846395
[TBL] [Abstract][Full Text] [Related]
17. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain.
van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R
J Pharmacol Exp Ther; 1994 Aug; 270(2):779-87. PubMed ID: 8071870
[TBL] [Abstract][Full Text] [Related]
19. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
Morfis M; Tilakaratne N; Furness SG; Christopoulos G; Werry TD; Christopoulos A; Sexton PM
Endocrinology; 2008 Nov; 149(11):5423-31. PubMed ID: 18599553
[TBL] [Abstract][Full Text] [Related]
20. In vitro autoradiographic localization of amylin binding sites in rat brain.
Sexton PM; Paxinos G; Kenney MA; Wookey PJ; Beaumont K
Neuroscience; 1994 Sep; 62(2):553-67. PubMed ID: 7830897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]